Liabilities / Assets
69th percentile
Higher debt load relative to assets than 69% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.16x
Liabilities / Revenue
84th percentile
Higher debt load relative to revenue than 84% of similar nonprofits.
Net Margin
95th percentile
Higher net margin than 95% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
83rd percentile
Faster asset growth than 83% of similar nonprofits.
Revenue Growth
6th percentile
Faster revenue growth than 6% of similar nonprofits.
Balance Sheet
Assets
Up$610,615
Up $139,782 (+30%) from 2016
Net Assets
Up$513,655
Up $138,778 (+37%) from 2016
Liabilities
Up$96,960
Up $1,004 (+1.0%) from 2016
Revenue And Expenses
Revenue
Down$214,247
Down $169,310 (-44%) from 2016
Expenses
Down$67,276
Down $45,045 (-40%) from 2016
Net Income
Down$146,971
Down $124,265 (-46%) from 2016
Historical Trend
Filing Detail Status
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview
Mission
Oligo nation advocates and fundraises to support medical research into oligodendroglioma brain cancer. We engage with others in the oligodendroglioma community to raise money and we work with researchers and research institutions to identify opportunities to fund translational research that can potentially lead to new treatments in the next 5 years.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $610,615
- Liabilities
- $96,960
- Net assets
- $513,655
- Revenue
- $214,247
- Expenses
- $67,276
- Net income
- $146,971